Faeth Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 28

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $200M

  • Investors
  • 1

Faeth General Information

Description

Operator of a data-driven, evidence-based healthcare company intended to use a deep mechanistic understanding of cancer metabolism to help in the treatment of cancer. The company is focused on matching specific diets with tumor genotypes and treatment regimens that would limit the supply of energy and building blocks that tumors require to grow, helping patients in their cancer treatments.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 701 Tillery Street
  • Suite 12, Number 1010
  • Austin, TX 78702
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 701 Tillery Street
  • Suite 12, Number 1010
  • Austin, TX 78702
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Faeth Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 17-Feb-2026 $200M Completed Generating Revenue
4. Later Stage VC (Series A1) 20-Oct-2025 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series A) 18-Mar-2022 Completed Clinical Trials - Phase 1
2. Debt - PPP 30-Apr-2020 $101K Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2019 Completed Clinical Trials - Phase 1
To view Faeth’s complete valuation and funding history, request access »

Faeth Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-2
Seed-6
Seed-5 1,060,606 $0.000100 8% $1.65 $1.65 1x $1.65 1.66%
Seed-4 1,454,616 $0.000100 8% $1.03 $1.03 1x $1.03 2.28%
To view Faeth’s complete cap table history, request access »

Faeth Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a data-driven, evidence-based healthcare company intended to use a deep mechanistic understanding of cancer
Drug Discovery
Austin, TX
28 As of 2025

San Mateo, CA
 

Niel, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Faeth Competitors (73)

One of Faeth’s 73 competitors is Vivace Therapeutics, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vivace Therapeutics Venture Capital-Backed San Mateo, CA
etherna Formerly VC-backed Niel, Belgium
Altimmune Formerly VC-backed Gaithersburg, MD
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 73 competitors. Get the full list »

Faeth Patents

Faeth Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026207461-A1 Cancer therapies targeting vista Pending 27-Mar-2025
WO-2025216894-A1 Bispecific anti-vista and anti-cd28 binding proteins and uses thereof Pending 09-Apr-2024
WO-2025208086-A1 Dietary regimens and methods for treatment of colorectal cancer Pending 29-Mar-2024
WO-2025207968-A1 Hpd inhibitor compositions and methods of use Pending 27-Mar-2024
AU-2024315861-A1 Cancer therapies targeting vista as monotherapy or in combination with anti-pd1 antibody to treat cancer Pending 02-Aug-2023 C07K16/2827
To view Faeth’s complete patent history, request access »

Faeth Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Faeth Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Able Partners Venture Capital Minority
AgFunder Venture Capital Minority
Atacama Ventures Venture Capital Minority
Avicella Capital Venture Capital Minority
B Capital Group Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Faeth FAQs

  • When was Faeth founded?

    Faeth was founded in 2019.

  • Where is Faeth headquartered?

    Faeth is headquartered in Austin, TX.

  • What is the size of Faeth?

    Faeth has 28 total employees.

  • What industry is Faeth in?

    Faeth’s primary industry is Drug Discovery.

  • Is Faeth a private or public company?

    Faeth is a Private company.

  • What is the current valuation of Faeth?

    The current valuation of Faeth is .

  • What is Faeth’s current revenue?

    The current revenue for Faeth is .

  • How much funding has Faeth raised over time?

    Faeth has raised $92M.

  • Who are Faeth’s investors?

    Able Partners, AgFunder, Atacama Ventures, Avicella Capital, and B Capital Group are 5 of 14 investors who have invested in Faeth.

  • Who are Faeth’s competitors?

    Vivace Therapeutics, etherna, Altimmune, Oxford Biotherapeutics, and Inovio Pharmaceuticals are some of the 73 competitors of Faeth.

  • When was Faeth acquired?

    Faeth was acquired on 17-Feb-2026.

  • Who acquired Faeth?

    Faeth was acquired by Faeth Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process